R. Martin Chavez

Alphabet is a collection of companies, including Google, Verily Life Sciences, GV, Calico, and X. In October 2015, Alphabet became the parent holding company of Google, with the companies far afield of our main internet products contained in Alphabet.

Earli mission is to make cancer a benign experience. Rather than rely on biomarkers that cancer may - or often may not - naturally provide, Earlis technology *forces* cancer cells to make a synthetic, non-human biomarker using gene therapy approaches. Its called a Synthetic Biopsy. It can then localize the cancer in a PET scanner. Earli has been funded by Andreessen Horowitzs Bio Fund, Khosla, Perceptive Advisors, Casdin Capital, Sands Capital, Marc Benioff, Menlo Ventures, ZhenFund. Earli is based in the West Coast’s prime biotech hub in South San Francisco.

Cambrian Bio is a clinical-stage drug development company building the medicines that will modernize healthcare in the 21st century. Our focus lies in creating innovative therapeutics designed to treat and ultimately prevent some of todays most debilitating chronic diseases, including platforms targeting the critical metabolic pathways that decline with age such as AMPK activation, mitochondrial function, and mTORC1 inhibition, to extend the period of life spent in good health.

Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning and AI algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine. Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Montréal, New York, London, and the Oxford area. Learn more at www.Recursion.com, or connect on X (formerly Twitter) and LinkedIn.

Paige is using the power of AI to drive a new era of cancer discovery and treatment. To improve the lives of patients with cancer, Paige has created a cloud-based platform that transforms pathologists’ workflow and increases diagnostic confidence as well as productivity, all on a global scale. Paige is the first company to receive FDA approval for a clinical AI application in digital pathology. The same Paige technology empowers pharmaceutical companies to more effectively evaluate treatment options for patients and design new biomarkers for drug development so that every patient gets precise treatment options. Learn more about Paige: https://www.paige.ai

From the unlikeliest of beginnings—an opera company located hundreds of miles from any major city, featuring American singers in a wide-ranging and challenging repertory, and treating theatrical and musical values as equally important in its productions—The Santa Fe Opera has grown to become recognized as one of the world's leading cultural festivals.

Sema4 is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Sema4 is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. Centrellis®, our innovative health intelligence platform, is enabling us to generate a more complete understanding of disease and wellness and to provide science-driven solutions to the most pressing medical needs. Sema4 believes that patients should be treated as partners, and that data should be shared for the benefit of all. In addition to LinkedIn, stay connected with us via the following social media channels: - Twitter: https://twitter.com/sema4 - Facebook: https://www.facebook.com/Sema4/ - Instagram: https://www.instagram.com/sema4/

Alphabet is a collection of companies, including Google, Verily Life Sciences, GV, Calico, and X. In October 2015, Alphabet became the parent holding company of Google, with the companies far afield of our main internet products contained in Alphabet.

Sixth Street is a global investment firm with over $100 billion in assets under management and committed capital.* The firm uses its long-term flexible capital, data-enabled capabilities and One Team culture to develop themes and offer solutions to companies across all stages of growth. Founded in 2009, Sixth Street has more than 650 team members including over 280 investment professionals operating globally. We invest through our diversified, collaborative investment platforms: TAO, Growth, Direct Lending, Strategic Capital, Fundamental Strategies, Infrastructure, Insurance, Structured Products, Agriculture, and Credit Market Strategies. *AUM is presented as of 9/30/2024, unless otherwise noted. AUM includes the total fair value of investments of private investment funds (including leverage, where applicable), certain co-investment vehicles and accounts for which Sixth Street provides investment management or advisory services, as well as capital that such funds, vehicles and accounts have the right to call from investors pursuant to the terms of their capital commitments, and additional fundraising commitments and fund, vehicle and account liquidations since 9/30/2024. In the case of Sixth Street-managed business development companies and certain accounts for which Sixth Street provides investment management or advisory services, the value of non-investment assets is also included. With respect to Sixth Street-managed collateralized loan obligations, AUM reflects the face amount of debt and equity outstanding. AUM includes capital to be managed in connection with the strategic partnership discussed in the Sixth Street press release that can be accessed here. Calculation of AUM differs from the calculation of regulatory assets under management in Form ADV filings and may differ from the AUM calculation methodologies used by other investment managers.

Earli mission is to make cancer a benign experience. Rather than rely on biomarkers that cancer may - or often may not - naturally provide, Earlis technology *forces* cancer cells to make a synthetic, non-human biomarker using gene therapy approaches. Its called a Synthetic Biopsy. It can then localize the cancer in a PET scanner. Earli has been funded by Andreessen Horowitzs Bio Fund, Khosla, Perceptive Advisors, Casdin Capital, Sands Capital, Marc Benioff, Menlo Ventures, ZhenFund. Earli is based in the West Coast’s prime biotech hub in South San Francisco.

Cambrian Bio is a clinical-stage drug development company building the medicines that will modernize healthcare in the 21st century. Our focus lies in creating innovative therapeutics designed to treat and ultimately prevent some of todays most debilitating chronic diseases, including platforms targeting the critical metabolic pathways that decline with age such as AMPK activation, mitochondrial function, and mTORC1 inhibition, to extend the period of life spent in good health.

Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning and AI algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine. Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Montréal, New York, London, and the Oxford area. Learn more at www.Recursion.com, or connect on X (formerly Twitter) and LinkedIn.